CSPC Pharmaceutical Group Limited: all 344 studies

Page 3 of 4. Open to participants first (160), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced OsteoporosisStatus unknownNCT05397938Phase 2
• A Mass Balance and Biotransformation Study of [14C]SKLB1028 in Chinese Healthy Male SubjectsCompletedNCT05369858Phase 1
• A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.Active, not recruitingNCT05354089Phase 1
• A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults.Active, not recruitingNCT05354063Phase 1
• A Study of TG103 Injection in Type 2 Diabetes SubjectsStatus unknownNCT05348122Phase 2
• A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid LeukemiaTerminatedNCT05345938Phase 1/2
• A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid TumorsStatus unknownNCT05344742Phase 1
• DP303c in Patients With HER2-positive Unresectable Locally Advanced, Relapsed, or Metastaticbreast CancerStatus unknownNCT05334810Phase 2
• A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian CancerStatus unknownNCT05325229Phase 2
• A Study of TG103 Injection in Overweight or ObesityStatus unknownNCT05299697Phase 2
• Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With OsteoporosisStatus unknownNCT05278338Phase 2
• A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast CancerStatus unknownNCT05274893Phase 1
• A Study of NBL-012 in Healthy Chinese SubjectsCompletedNCT05259189Phase 1
• Clinical Pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection in Recurrent/Refractory Lymphoma SubjectsCompletedNCT05173545Phase 1
• A Study to Evaluate the Effect of Different Meal Types on the Pharmacokinetics of DBPR108 in Healthy SubjectsCompletedNCT05150626Phase 1
• A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus PatientsCompletedNCT05146869Phase 1
• Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung CancerStatus unknownNCT05132777Phase 2
• A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid TumorsStatus unknownNCT05125523Phase 1
• Study of HA121-28 in Patients With Non-Small Cell Lung CancerStatus unknownNCT05117658Phase 2
• A Study To Evaluate the Safety, Tolerance, Pharmacokinetics/Pharmacodynamics and Efficacy of SYHA1402 Tablets For the Treatment of Patients With Diabetic Peripheral Neuropathy in ChinaStatus unknownNCT05116111Phase 2
• A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid TumorsStatus unknownNCT05114915Phase 1
• A Dose Escalation and Food Effect Study of SKLB1028 in Healthy SubjectsCompletedNCT05109663Phase 1
• A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and FeverStatus unknownNCT05108545Phase 3
• A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic CancerStatus unknownNCT05100329Phase 2
• A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)Status unknownNCT05100303Phase 1/2
• A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant TumorSuspendedNCT05089461Phase 2
• A Study to Evaluate Relative Bioavailability and Food-Effect of HA121-28 Tablet B in Healthy SubjectsCompletedNCT05072535Phase 1
• A Study of SKLB1028 in Patients With Advanced Solid TumorStatus unknownNCT05072522Phase 1
• Mass Balance and Biotransformation Study of [14C]DBPR108 in HumanCompletedNCT05072028Phase 1
• A Study to Investigate the Drug-drug Interactions (DDIs) Between SKLB1028 and Midazolam in Healthy SubjectsCompletedNCT05070195Phase 1
• A Study to Investigate the Drug-drug Interactions (DDIs) of SKLB1028 With Itraconazole, Gemfibrozil or Rifampicin in Healthy SubjectsStatus unknownNCT05069870Phase 1
• A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC)Status unknownNCT05068141Phase 2
• A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 DiabetesStatus unknownNCT05063253Phase 2
• Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MMStatus unknownNCT05052970Phase 1
• Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic AdenocarcinomaStatus unknownNCT05047991Phase 2
• A Study to Evaluate the Drug-drug Interactions (DDIs) of DBPR108 With Warfarin Sodium, Digoxin, Probenecid in Healthy SubjectsCompletedNCT05045313Phase 1
• A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)Status unknownNCT05027204Phase 1/2
• Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With DepressionStatus unknownNCT05018013Phase 2
• Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid TumorStatus unknownNCT05009966Phase 1
• Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract CancerTerminatedNCT05009953Phase 2
• A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy SubjectsCompletedNCT04993222Phase 1
• Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOCStatus unknownNCT04983550Phase 2
• A Study of SYHA1805 in Healthy SubjectsStatus unknownNCT04977570Phase 1
• Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refractory Chronic Spontaneous UrticariaStatus unknownNCT04944602Phase 3
• A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast CancerTerminatedNCT04927481Phase 2
• A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid TumorsCompletedNCT04921878Phase 1
• Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML PatientsStatus unknownNCT04920500Not applicable
• A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck CancersCompletedNCT04902027Phase 1
• A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue SarcomaTerminatedNCT04900766Phase 1
• A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With OsteosarcomaStatus unknownNCT04886765Phase 1/2
• Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical CancerStatus unknownNCT04886700Phase 2
• The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy SubjectsStatus unknownNCT04880512Phase 1
• A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy SubjectsCompletedNCT04859452Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal ImpairmentCompletedNCT04859439Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic ImpairmentCompletedNCT04859426Phase 1
• A Study of TG103 Injection in Overweight/Obese Subjects Without DiabetesCompletedNCT04855292Phase 1
• A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male SubjectsCompletedNCT04839744Phase 1
• Study of DP303c Injection in Patients With Advanced Ovarian CancerStatus unknownNCT04828616Phase 2
• Study of DP303c Injection in Patients With Advanced or Metastatic Gastric CancerStatus unknownNCT04826107Phase 2
• The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and TaxotereStatus unknownNCT04811118Phase 1
• A Study of TG103 in Subjects With Type 2 DiabetesStatus unknownNCT04790006Phase 1
• A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC)Status unknownNCT04787328Phase 2
• A Study of HA121-28 Tablets in Advanced Biliary Tract CancerTerminatedNCT04784520Phase 2
• Study of Irinotecan Liposome Injection in Patients With Advanced Breast CanceCompletedNCT04728035Phase 1
• Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)CompletedNCT04727853Phase 2
• A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid TumorStatus unknownNCT04719065Phase 1
• A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric CarcinomaTerminatedNCT04718402Phase 1
• A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian CancerTerminatedNCT04718376Phase 1
• A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular LymphomaStatus unknownNCT04707079Phase 2
• Efficacy and Safety of JMT101 in Patients With Advanced Solid TumorStatus unknownNCT04689100Phase 1
• Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCLActive, not recruitingNCT04668690Phase 3
• A Study of SYHA1805 in Healthy Adult SubjectsStatus unknownNCT04645901Phase 1
• Efficacy and Safety of JMT103 in Patients With Bone Metastases From Solid TumorsCompletedNCT04630522Phase 1
• Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCLTerminatedNCT04548700Phase 1
• Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCLTerminatedNCT04509466Phase 1/2
• Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic SyndromeStatus unknownNCT04500886Not applicable
• Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological MalignanciesStatus unknownNCT04497701Not applicable
• Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's LymphomaStatus unknownNCT04497688Not applicable
• Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.Status unknownNCT04482257Phase 1
• Evaluation of the Safety and Efficacy of Albumin-bound DocetaxelStatus unknownNCT04471675Phase 1
• A Bioequivalence Study of Doxorubicin Hydrochloride Liposome InjectionCompletedNCT04460820Not applicable
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of SYHA1402 in Healthy SubjectsStatus unknownNCT04453618Phase 1
• Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung CancerStatus unknownNCT04448379Phase 1
• A Study of SYHA1807 in Subjects With Extensive-Stage Small Cell Lung CancerStatus unknownNCT04404543Phase 1
• Study of Desvenlafaxine in Treating Major Depressive Disorder.CompletedNCT04364997Phase 3
• A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line ChemotherapyTerminatedNCT04352413Phase 2
• A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCCStatus unknownNCT04331743Phase 1
• A Study of CSPCHA131 in Patients With Advanced Solid TumorStatus unknownNCT04325711Phase 1
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid TumorsStatus unknownNCT04309968Phase 1
• Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of BoneStatus unknownNCT04255576Phase 1/2
• Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic CancerStatus unknownNCT04239001Not applicable
• Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive AspergillosisStatus unknownNCT04225195Phase 2
• A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DMCompletedNCT04218734Phase 3
• A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCMTerminatedNCT04198480Phase 1/2
• Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis ObliteranStatus unknownNCT04197323Phase 2
• Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy VolunteersCompletedNCT04161547Phase 1
• A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus PatientsCompletedNCT04161430Phase 3
• Study of DP303c Administered Intravenously to Subjects With HER2-Positive in Advanced Solid TumorsStatus unknownNCT04146610Phase 1
• DBPR108 Tablets in Type 2 Diabetes Mellitus PatientsCompletedNCT04124484Phase 2
• Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant TumorsCompletedNCT04060290

← CSPC Pharmaceutical Group Limited overview and focus areas